Y-Intercept (HK)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2M | Buy |
168,378
+141,843
| +535% | +$11.1M | 0.32% | 38 |
|
|
2025
Q1 | $1.92M | Sell |
26,535
-11,686
| -31% | -$847K | 0.13% | 197 |
|
|
2024
Q4 | $2.83M | Buy |
38,221
+24,398
| +177% | +$1.81M | 0.19% | 138 |
|
|
2024
Q3 | $912K | Sell |
13,823
-3,122
| -18% | -$206K | 0.06% | 487 |
|
|
2024
Q2 | $1.57M | Buy |
+16,945
| New | +$1.57M | 0.09% | 325 |
|
|
2024
Q1 | – | Sell |
-13,034
| Closed | -$994K | – | 1480 |
|
|
2023
Q4 | $994K | Sell |
13,034
-48,441
| -79% | -$3.69M | 0.09% | 320 |
|
|
2023
Q3 | $4.26M | Buy |
61,475
+44,860
| +270% | +$3.11M | 0.42% | 27 |
|
|
2023
Q2 | $1.57M | Buy |
16,615
+7,893
| +90% | +$745K | 0.17% | 155 |
|
|
2023
Q1 | $722K | Sell |
8,722
-10,324
| -54% | -$854K | 0.08% | 369 |
|
|
2022
Q4 | $1.42M | Sell |
19,046
-22,190
| -54% | -$1.66M | 0.21% | 113 |
|
|
2022
Q3 | $3.41M | Buy |
+41,236
| New | +$3.41M | 0.34% | 50 |
|
|
2021
Q4 | – | Sell |
-22,795
| Closed | -$2.58M | – | 659 |
|
|
2021
Q3 | $2.58M | Buy |
+22,795
| New | +$2.58M | 0.47% | 28 |
|